Vol. 11. Discover the Essential Conference Sessions

Only 7 weeks to go

Time to pre-register and plan your visit - BIX 2024 awaits you!

Please direct your attention to the pivotal conference sessions.
Gain profound insights about the status and future outlook of
mRNA Biotherapeutics from two conference sessions with MIT.

📍 Meet MIT at BIX 2024 ▶ Booth : L11


The Current Status and Promise of mRNA Biotherapeutics 

[Day 1] July 10, 2024 │ 10:00-10:40 (40')

The value of mRNA biotherapeutics was demonstrated for the mRNA-based COVID-19 vaccine that was developed for the last pandemic. The ability to quickly produce a biotherapeutic via cell-free synthesis enables the potential of greatly reducing process development speed – which was critical during the pandemic – but only the potential for reduced production and purification costs. This presentation will discuss the current status and promise for both vaccine and non-vaccine biotherapeutic applications.


Professor Richard D. Braatz is an internationally recognized researcher, honored with the American Institute of Chemical Engineers (AIChE) Innovation Award. along with numerous publication and investigator awards. His expertise spans bio-pharmaceutical manufacturing, data analytics and machine learning, applied mathematics, and control theory. Dr. Braatz and his colleagues at MIT are driving advancements in the biopharmaceutical industry, notably through projects like designing the world's first fully integrated continuous mRNA manufacturing platform, funded by the U.S. Food and Drug Administration (FDA).

Want to join? Secure your spot now with a Prime Pass! ▶



Digital Twin for Continuous mRNA Manufacturing 

[Day 1] July 10, 2024  │ 13:00-14:30 (90') │ Conference Room 317, COEX

▶A Digital Twin for Continuous mRNA Manufacturing

 Richard D. Braatz, MIT

▶MIT Startup Lightning Talks

 BioMixing / Kano Therapeutics / Quantiscope / Tiba Biotech




[email protected]
1622-24, Block A, Terra Tower 2, 201, Songpa-daero, Songpa-gu, Seoul, Korea
+82 2-561-6169